Wiley Agent Knowledge Base: Life Sciences
Wiley · Marketing & Sales
Certification per AWS Marketplace.
Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
Drug development timelines are unforgiving, and regulatory standards keep rising. While many AI models and agentic solutions struggle with inconsistent or incomplete research data due to limited access to up to date full text scientific content.
That's why, leading pharmaceutical companies rely on Wiley's comprehensive scientific intelligence to power scientific discovery. Our peer reviewed content spans the entire drug development pipeline, supporting every stage of the journey from target identification and compound optimization to clinical trial design and regulatory submission. With structured metadata and validated research protocols, your AI can accelerate lead compound identification, predict drug drug interactions more accurately, and streamline regulatory pathways.
Show the rest of the publisher’s description (18 more lines)
When you are developing therapies that could help millions of patients, your AI deserves the most rigorous scientific foundation available. Wiley's full text corpus of agent Life Sciences knowledge base helps you win with:
- Expert insights: Tap into 280 plus life science and pharma full text journals, edited and compiled by domain experts, and published in partnership with over 160 societies, including Engineering in Life Sciences, Advanced Biology, The FEBS Journal, Scientifica, Cell Biochemistry and Function, Drug Development Research, Advanced Biosystems, Advances in Biology, American Journal of Anatomy, Drug Testing Analysis
- Accelerate your AI Agent development through seamless, secure delivery: Receive the latest machine readable, metadata rich, AWS Bedrock compatible embedded content over real time API endpoints that slot straight into your AWS environment, reducing overall integration effort, all while leveraging powerful AWS infrastructure, AI tools and ecosystem to streamline innovation and agent development. Our knowledge base will be refreshed with newly published articles to reflect ongoing scientific breakthrough in Life Sciences.
- Built in compliance: Our audit ready content supports regulatory alignment, protects intellectual property and enables responsible, transparent innovation, eliminating the legal and reputational risk of unlicensed or scraped data.
- Maximize your AWS investment: Draw down on your annual AWS commitment spend, without the need to find incremental budget to build trusted, content rich AI solutions that advances scientific discovery.
Wiley Agent Knowledge Base: Life Sciences is the ideal data layer for Life Sciences and pharmaceutical enterprises building RAG applications and multi agent solutions, unlocking value across many use cases, including:
A) Literature Search and Summarization: Efficiently identify, summarize, and evaluate relevant literature as individual articles or in aggregation, enabling new ways of doing research and delivering reliable and cited insights in seconds, rather than the current hours to days long manual process.
B) Target Identification and Validation: Identify and validate potential drug targets by analyzing large datasets of biological information, including genetic data, protein structures, and disease models.
C) Compound Analysis: Analyze the properties and interactions of chemical compounds, assisting in the design and optimization of new drugs.
D) Drug Design: generate new drug candidates based on existing knowledge and data, potentially accelerating the drug development process.
E) Clinical Trial design: Optimize clinical trial design by identifying relevant patient groups, inclusion and exclusion criteria, and potential outcomes based on previous research.
F) Pharmacovigilance: Tracking and analyzing adverse drug reactions, helping to identify potential safety issues.
G) Clinician education and sales enablement: Personalized, evidence backed briefs help field teams and HCPs stay current on the latest findings, boosting engagement and therapy adoption.
Wiley has also demonstrated experience in collaborating with leading innovators to deliver trusted, compliance ready knowledge for mission critical AI. We have several active collaboration programs, including:
AWS: First scientific publisher to embed a full text literature search agent in the AWS Healthcare and Life Sciences Agent Toolkit, giving cloud customers turnkey access to licensed research inside their own AWS private cloud.
Perplexity AI: Integrates Wiley journals and textbooks into the Perplexity answer engine, allowing students, researchers and clinicians to query scholarly content through conversational AI.
European Space Agency (EVE): Provides a curated Earth science corpus to train ESAs Earth Virtual Expert, showcasing how domain specific, licensed content strengthens specialized language models.
Wiley's Agent Knowledge Base: Life Sciences is now available on AWS Marketplace through Private Offers. Select Request private offer to be contacted by the Wiley Sales team and learn how our trusted, peer-reviewed content can accelerate your enterprise AI initiatives.
Highlights
Highlighted by the publisher on AWS Marketplace.
Expert insights: Tap into 280 plus life science and pharma full text journals, edited and compiled by domain experts, and published in partnership with over 160 societies, including Engineering in Life Sciences; Advanced Biology, The FEBS Journal, Scientifica, Cell Biochemistry and Function, Drug Development Research, Advanced Biosystems, Advances in Biology, American Journal of Anatomy, Drug Testing Analysis.
Maximize your AWS investment: Draw down on your annual AWS commitment spend, without the need to find incremental budget to build trusted, content rich AI solutions that advances scientific discovery.
Accelerate you AI Agent development through seamless, secure delivery: Receive the latest machine readable, metadata rich, AWS Bedrock compatible embedded content over real time API endpoints that slot straight into your AWS environment, reducing overall integration effort, all while leveraging powerful AWS infrastructure, AI tools and ecosystem to streamline innovation and agent development. Wiley's content is refreshed the moment new articles are published.
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Plans and pricing as listed
1 listed- Units
Refund terms
As stated by the publisher on AWS Marketplace.
In consideration of the rights granted to Customer under the Agreement, Customer shall pay to Wiley a non-refundable fee, payable 30 days from invoice date.
Sources
Publisher resources
4 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.